Trial
NCT01286038
Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Collaborators
GlaxoSmithKline
Condition
Myelodysplastic Syndrome (MDS)
Intervention
Eltrombopag
Why stopped
Lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-11-07